BerandaCORT • NASDAQ
add
Corcept Therapeutics Incorporated
Tutup sebelumnya
$54,79
Rentang hari
$51,51 - $55,22
Rentang tahun
$20,84 - $61,66
Kapitalisasi pasar
5,43Â M USD
Volume Rata-Rata
1,12Â jt
Rasio P/E
40,82
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 182,55Â jt | 47,69% |
Biaya operasional | 133,08Â jt | 46,60% |
Laba bersih | 47,21Â jt | 50,47% |
Margin laba bersih | 25,86 | 1,85% |
Penghasilan per saham | 0,41 | 46,43% |
EBITDA | 46,92Â jt | 49,37% |
Tarif pajak efektif | 10,82% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 380,34Â jt | 7,07% |
Total aset | 784,26Â jt | 32,02% |
Total liabilitas | 145,42Â jt | 9,88% |
Total ekuitas | 638,84 jt | — |
Saham yang beredar | 104,78 jt | — |
Harga terhadap nilai buku | 8,98 | — |
Tingkat pengembalian aset | 15,54% | — |
Tingkat pengembalian modal | 18,68% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 47,21Â jt | 50,47% |
Kas dari operasi | 73,83Â jt | 39,54% |
Kas dari investasi | -44,04Â jt | 59,81% |
Kas dari pembiayaan | -21,09Â jt | -438,61% |
Perubahan kas bersih | 8,70Â jt | 114,36% |
Arus kas bebas | 70,22Â jt | 28,78% |
Tentang
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD. Wikipedia
Didirikan
13 Mei 1998
Kantor pusat
Situs
Karyawan
352
